Like many have said on here before, the majority of institutions...

Like many have said on here before, the majority of institutions got on at $0.40 on the capital raising. Feel there is very big support there. No surprise some 'professional' investors sold out at $0.50 down on release of the quarterly report (why not make a quick 25% in a few months?).

Slew of reports due out:

CelGro Tendon results overdue from 2Q.
CelGro Nerve results update promised in 3Q
Johnson and Johnson ATI rotator cuff recruitment to finish in 3Q - announcement likely in this quarter

Partnerships likely to be announced before year end according to previous announcements. I also expect some more media focus perhaps with some ATI patient stories - certainly I have been badgering management to do some more high profile sports starts like they did with Daniel Kerr of West Coast Eagles and let them get the story out there. Physicians want more and more clinical trial results to convince them to use (as the company is constantly successfully doing) but if the story is out there on social media, more and more patients will turn up demanding ATI rather than surgery....just as I did myself 5 years ago thankfully.